About JW Holdings
JW Group started the holding company system in 2007 to enhance the efficiency and establish responsibility management in the rapidly changing business environment. JW Holdings makes profit mainly from export of medicine and medical supplies as well as equity interest, rental income, brand royalties, service fees from subsidiary companies. We have been cooperated with about 40 global medicine companies such as Chugai, Roche, Abbott, etc., and based on such competitiveness, have been expanding our business scope to raw material,completion medicine and medical supplies, and medical appliance field. We have also completed the construction of infrastructure for penetration of global market such as high-tech manufacturing facility, in accord with the global cGMP standard, in Dangjin, Chungcheongnam-do.
Subsidiary companies:
JW Pharmaceutical: www.jw-pharma.co.kr/pharma/en/main.jsp
JW Shinyak: www.jw-shinyak.co.kr/shinyak/en/main.jsp
JW Life Science: www.jw-lifescience.co.kr/lifescience/en/main.jsp
JW Medical: www.jw-lifescience.co.kr/lifescience/en/main.jsp
JW Industrial: jw-industrial.co.kr/
|
|
|
51-200 employees
View all JW Holdings employees
|
|
Pharmaceuticals
|
|
Seoul Korea
|
|
2007
|
|
Antibiotics, Medical Devices, 3 Chamber Solutions, Active Pharmaceutical Igredients, Aminoacid Solutions, Anticancer Agents, Antigungal Agents, Basic I.v. Solutions, Gastrointestinal Agents, Lipid Emulsions, Non-Pvc Containers
|
JW Holdings Alternatives
Frequently Asked Questions about JW Holdings
Kyung Lee is the CEO of JW Holdings. To contact Kyung Lee email at [email protected].
JW Holdings Staff Directory
Search JW Holdings Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.
